Angela Tatiana Alistar, MD, discusses the need to develop biomarkers in pancreatic cancer.
Angela Tatiana Alistar, MD
Advertisement
Articles by Angela Tatiana Alistar, MD
Advertisement
Latest Updated Articles
Dr. Alistar on the Need to Develop Biomarkers in Pancreatic CancerPublished: June 22nd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
5